Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

Management of suspected and confirmed recurrent venous thrombosis while on anticoagulant therapy. What next?

Rodger MA, Miranda S, Delluc A, Carrier M.

Thromb Res. 2019 Jun 26;180:105-109. doi: 10.1016/j.thromres.2019.06.017. [Epub ahead of print] Review.

2.

Who should get long-term anticoagulant therapy for venous thromboembolism and with what?

Rodger MA, Le Gal G.

Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):426-431. doi: 10.1182/asheducation-2018.1.426. Review.

PMID:
30504342
3.

American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy.

Bates SM, Rajasekhar A, Middeldorp S, McLintock C, Rodger MA, James AH, Vazquez SR, Greer IA, Riva JJ, Bhatt M, Schwab N, Barrett D, LaHaye A, Rochwerg B.

Blood Adv. 2018 Nov 27;2(22):3317-3359. doi: 10.1182/bloodadvances.2018024802. Review.

4.

Who should get long-term anticoagulant therapy for venous thromboembolism and with what?

Rodger MA, Le Gal G.

Blood Adv. 2018 Nov 13;2(21):3081-3087. doi: 10.1182/bloodadvances.2018020230. Review.

5.

Serial imaging after pulmonary embolism and correlation with functional limitation at 12 months: Results of the ELOPE Study.

Ma KA, Kahn SR, Akaberi A, Dennie C, Rush C, Granton JT, Anderson D, Wells PS, Rodger MA, Solymoss S, Kovacs MJ, Rudski L, Shimony A, Hernandez P, Aaron SD, Pena E, Abikhzer G, Hirsch AM; ELOPE Study group.

Res Pract Thromb Haemost. 2018 Jun 17;2(4):670-677. doi: 10.1002/rth2.12123. eCollection 2018 Oct.

6.

"HERDOO2" clinical decision rule to guide duration of anticoagulation in women with unprovoked venous thromboembolism. Can I use any d-Dimer?

Rodger MA, Le Gal G, Langlois NJ, Gin B, Mallick R, Giulivi A, Freedman M, Kovacs MJ; REVERSE II investigators.

Thromb Res. 2018 Sep;169:82-86. doi: 10.1016/j.thromres.2018.07.020. Epub 2018 Jul 17.

7.

Are Anti-β2 Glycoprotein 1 Antibodies Associated with Placenta-Mediated Pregnancy Complications? A Nested Case-Control Study.

Skeith L, Abou-Nassar KE, Walker M, Ramsay T, Booth R, Wen SW, Smith GN, Rodger MA.

Am J Perinatol. 2018 Sep;35(11):1093-1099. doi: 10.1055/s-0038-1641168. Epub 2018 Apr 10.

PMID:
29635655
8.

Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty.

Anderson DR, Dunbar M, Murnaghan J, Kahn SR, Gross P, Forsythe M, Pelet S, Fisher W, Belzile E, Dolan S, Crowther M, Bohm E, MacDonald SJ, Gofton W, Kim P, Zukor D, Pleasance S, Andreou P, Doucette S, Theriault C, Abianui A, Carrier M, Kovacs MJ, Rodger MA, Coyle D, Wells PS, Vendittoli PA.

N Engl J Med. 2018 Feb 22;378(8):699-707. doi: 10.1056/NEJMoa1712746.

9.

The authors respond to "Thrombophilia testing in venous thromboembolism".

Khan F, Le Gal G, Rodger MA.

CMAJ. 2018 Feb 12;190(6):E172. doi: 10.1503/cmaj.68991. No abstract available.

10.

Predicting the risk of recurrent venous thromboembolism in patients with cancer: A prospective cohort study.

van Es N, Louzada M, Carrier M, Tagalakis V, Gross PL, Shivakumar S, Rodger MA, Wells PS.

Thromb Res. 2018 Mar;163:41-46. doi: 10.1016/j.thromres.2018.01.009. Epub 2018 Jan 9.

PMID:
29353682
11.

Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis.

Khan F, Rahman A, Carrier M, Kearon C, Schulman S, Couturaud F, Prandoni P, Eichinger S, Becattini C, Agnelli G, Büller HR, Brighton TA, Palareti G, Pinede L, Sabri E, Hutton B, Wells GA, Rodger MA; MARVELOUS Collaborators.

BMJ Open. 2017 Sep 21;7(9):16950. doi: 10.1136/bmjopen-2017-016950.

12.

Stopping anticoagulation in a woman with unprovoked venous thromboembolism.

Khan F, Le Gal G, Rodger MA.

CMAJ. 2017 Sep 5;189(35):E1112-E1114. doi: 10.1503/cmaj.170327. No abstract available.

13.

Pulmonary Complications of Pregnancy: Venous Thromboembolism.

Skeith L, Rodger MA.

Semin Respir Crit Care Med. 2017 Apr;38(2):135-147. doi: 10.1055/s-0037-1602241. Epub 2017 May 22. Review.

PMID:
28561245
14.

Prevention of early-onset pre-eclampsia - Authors' reply.

Rodger MA; Low-Molecular-Weight Heparin for Placenta-Mediated Pregnancy Complications Study Group.

Lancet. 2017 Apr 15;389(10078):1515. doi: 10.1016/S0140-6736(17)30951-0. No abstract available.

PMID:
28422023
15.

Quality of Life, Dyspnea, and Functional Exercise Capacity Following a First Episode of Pulmonary Embolism: Results of the ELOPE Cohort Study.

Kahn SR, Akaberi A, Granton JT, Anderson DR, Wells PS, Rodger MA, Solymoss S, Kovacs MJ, Rudski L, Shimony A, Dennie C, Rush C, Hernandez P, Aaron SD, Hirsch AM.

Am J Med. 2017 Aug;130(8):990.e9-990.e21. doi: 10.1016/j.amjmed.2017.03.033. Epub 2017 Apr 8.

PMID:
28400247
16.

Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study.

Rodger MA, Le Gal G, Anderson DR, Schmidt J, Pernod G, Kahn SR, Righini M, Mismetti P, Kearon C, Meyer G, Elias A, Ramsay T, Ortel TL, Huisman MV, Kovacs MJ; REVERSE II Study Investigators.

BMJ. 2017 Mar 17;356:j1065. doi: 10.1136/bmj.j1065.

17.

Risk of venous thromboembolism in pregnant women with essential thrombocythemia: a systematic review and meta-analysis.

Skeith L, Carrier M, Robinson SE, Alimam S, Rodger MA.

Blood. 2017 Feb 23;129(8):934-939. doi: 10.1182/blood-2016-09-728006. Epub 2017 Jan 3. Review.

18.

Functional and Exercise Limitations After a First Episode of Pulmonary Embolism: Results of the ELOPE Prospective Cohort Study.

Kahn SR, Hirsch AM, Akaberi A, Hernandez P, Anderson DR, Wells PS, Rodger MA, Solymoss S, Kovacs MJ, Rudski L, Shimony A, Dennie C, Rush C, Geerts WH, Aaron SD, Granton JT.

Chest. 2017 May;151(5):1058-1068. doi: 10.1016/j.chest.2016.11.030. Epub 2016 Dec 6.

PMID:
27932051
19.

Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials.

Rodger MA, Gris JC, de Vries JIP, Martinelli I, Rey É, Schleussner E, Middeldorp S, Kaaja R, Langlois NJ, Ramsay T, Mallick R, Bates SM, Abheiden CNH, Perna A, Petroff D, de Jong P, van Hoorn ME, Bezemer PD, Mayhew AD; Low-Molecular-Weight Heparin for Placenta-Mediated Pregnancy Complications Study Group.

Lancet. 2016 Nov 26;388(10060):2629-2641. doi: 10.1016/S0140-6736(16)31139-4. Epub 2016 Oct 6.

PMID:
27720497
20.

Low molecular weight heparin to prevent postpartum venous thromboembolism: A pilot study to assess the feasibility of a randomized, open-label trial.

Rodger MA, Phillips P, Kahn SR, Bates S, McDonald S, Khurana R, James AH, Konkle BA; PROSPER Investigators: Tim Ramsay, Dean Fergusson, Anne McLeod, Wee Shian Chan, Rshmi Khurana, Kara Narenberg, Haim Abenhaim, John Heit, Ghada Bourjeilly, Paul Gibson, Kent Bailey.

Thromb Res. 2016 Jun;142:17-20. doi: 10.1016/j.thromres.2016.04.004. Epub 2016 Apr 9. No abstract available.

PMID:
27096813
21.

Long-term risk of venous thrombosis after stopping anticoagulants for a first unprovoked event: A multi-national cohort.

Rodger MA, Scarvelis D, Kahn SR, Wells PS, Anderson DA, Chagnon I, Le Gal G, Gandara E, Solymoss S, Sabri E, Kovacs J, Kovacs MJ.

Thromb Res. 2016 Jul;143:152-8. doi: 10.1016/j.thromres.2016.03.028. Epub 2016 Mar 29.

22.

Effectiveness of a computerized decision support system for anticoagulation management in hemodialysis patients: A before-after study.

Clark EG, Rodger MA, Ramsay TO, Knoll GA.

Hemodial Int. 2016 Oct;20(4):530-536. doi: 10.1111/hdi.12411. Epub 2016 Mar 17.

PMID:
26990353
23.

International Society on Thrombosis and Haemostasis core curriculum project: core competencies in clinical thrombosis and hemostasis: comment.

Skeith L, Rodger MA, Lee AY, Kahn SR, Bates SM, Gonsalves C.

J Thromb Haemost. 2016 Jun;14(6):1316-7. doi: 10.1111/jth.13303. Epub 2016 Apr 9. No abstract available.

24.

A meta-analysis of low-molecular-weight heparin to prevent pregnancy loss in women with inherited thrombophilia.

Skeith L, Carrier M, Kaaja R, Martinelli I, Petroff D, Schleußner E, Laskin CA, Rodger MA.

Blood. 2016 Mar 31;127(13):1650-5. doi: 10.1182/blood-2015-12-626739. Epub 2016 Feb 2. Review.

25.

Screening for Occult Cancer in Unprovoked Venous Thromboembolism.

Carrier M, Lazo-Langner A, Shivakumar S, Tagalakis V, Zarychanski R, Solymoss S, Routhier N, Douketis J, Danovitch K, Lee AY, Le Gal G, Wells PS, Corsi DJ, Ramsay T, Coyle D, Chagnon I, Kassam Z, Tao H, Rodger MA; SOME Investigators.

N Engl J Med. 2015 Aug 20;373(8):697-704. doi: 10.1056/NEJMoa1506623. Epub 2015 Jun 22.

26.

Is thrombophilia associated with placenta-mediated pregnancy complications? A prospective cohort study: reply.

Rodger MA, Langlois NJ.

J Thromb Haemost. 2015 Aug;13(8):1536-7. doi: 10.1111/jth.13015. Epub 2015 Jun 19. No abstract available.

27.

Recurrent pregnancy loss: drop the heparin needles….

Rodger MA.

Blood. 2015 Apr 2;125(14):2179-80. doi: 10.1182/blood-2015-02-626457. No abstract available.

28.

Dalteparin for pregnant women with thrombophilia - authors' reply.

Rodger MA, Hague WM, Kingdom J, Kahn SR, Wells PS.

Lancet. 2015 Feb 21;385(9969):690. doi: 10.1016/S0140-6736(15)60287-2. Epub 2015 Feb 20. No abstract available.

PMID:
25706216
29.

Inflammation markers and their trajectories after deep vein thrombosis in relation to risk of post-thrombotic syndrome.

Rabinovich A, Cohen JM, Cushman M, Wells PS, Rodger MA, Kovacs MJ, Anderson DR, Tagalakis V, Lazo-Langner A, Solymoss S, Miron MJ, Yeo E, Smith R, Schulman S, Kassis J, Kearon C, Chagnon I, Wong T, Demers C, Hanmiah R, Kaatz S, Selby R, Rathbun S, Desmarais S, Opatrny L, Ortel TL, Ginsberg JS, Kahn SR.

J Thromb Haemost. 2015 Mar;13(3):398-408. doi: 10.1111/jth.12814. Epub 2015 Feb 10.

30.

Low-molecular-weight heparin to prevent postpartum venous thromboembolism. A pilot randomised placebo-controlled trial.

Rodger MA, Phillips P, Kahn SR, James AH, Konkle BA; PROSPER Investigators.

Thromb Haemost. 2015 Jan;113(1):212-6. doi: 10.1160/TH14-06-0485. Epub 2014 Nov 6.

PMID:
25373438
31.

Meta-analysis to assess the quality of international normalized ratio control and associated outcomes in venous thromboembolism patients.

Chitsike RS, Kahn SR, Rodger MA; REVERSE investigators.

Thromb Res. 2014 Dec;134(6):1358. doi: 10.1016/j.thromres.2014.08.022. Epub 2014 Sep 9. No abstract available.

PMID:
25263018
32.

Clinical and safety outcomes associated with treatment of acute venous thromboembolism: a systematic review and meta-analysis.

Castellucci LA, Cameron C, Le Gal G, Rodger MA, Coyle D, Wells PS, Clifford T, Gandara E, Wells G, Carrier M.

JAMA. 2014 Sep 17;312(11):1122-35. doi: 10.1001/jama.2014.10538. Review.

PMID:
25226478
33.

Graduated compression stockings to treat acute leg pain associated with proximal DVT. A randomised controlled trial.

Kahn SR, Shapiro S, Ducruet T, Wells PS, Rodger MA, Kovacs MJ, Anderson D, Tagalakis V, Morrison DR, Solymoss S, Miron MJ, Yeo E, Smith R, Schulman S, Kassis J, Kearon C, Chagnon I, Wong T, Demers C, Hanmiah R, Kaatz S, Selby R, Rathbun S, Desmarais S, Opatrny L, Ortel TL, Galanaud JP, Ginsberg JS.

Thromb Haemost. 2014 Dec;112(6):1137-41. doi: 10.1160/TH14-05-0430. Epub 2014 Aug 28.

PMID:
25183442
34.

Clinical decision rules and D-Dimer in venous thromboembolism: current controversies and future research priorities.

Rodger MA, Le Gal G, Wells P, Baglin T, Aujesky D, Righini M, Palareti G, Huisman M, Meyer G.

Thromb Res. 2014 Oct;134(4):763-8. doi: 10.1016/j.thromres.2014.07.031. Epub 2014 Aug 4. Review.

PMID:
25129416
35.

Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial.

Rodger MA, Hague WM, Kingdom J, Kahn SR, Karovitch A, Sermer M, Clement AM, Coat S, Chan WS, Said J, Rey E, Robinson S, Khurana R, Demers C, Kovacs MJ, Solymoss S, Hinshaw K, Dwyer J, Smith G, McDonald S, Newstead-Angel J, McLeod A, Khandelwal M, Silver RM, Le Gal G, Greer IA, Keely E, Rosene-Montella K, Walker M, Wells PS; TIPPS Investigators.

Lancet. 2014 Nov 8;384(9955):1673-83. doi: 10.1016/S0140-6736(14)60793-5. Epub 2014 Jul 24.

PMID:
25066248
36.

Therapies for venous thromboembolism--reply.

Wells PS, Forgie MA, Rodger MA.

JAMA. 2014 Jun 25;311(24):2543-4. doi: 10.1001/jama.2014.6123. No abstract available.

PMID:
25058093
37.

Low-molecular-weight heparin for prevention of placenta-mediated pregnancy complications: protocol for a systematic review and individual patient data meta-analysis (AFFIRM).

Rodger MA, Langlois NJ, de Vries JI, Rey E, Gris JC, Martinelli I, Schleussner E, Ramsay T, Mallick R, Skidmore B, Middeldorp S, Bates S, Petroff D, Bezemer D, van Hoorn ME, Abheiden CN, Perna A, de Jong P, Kaaja R.

Syst Rev. 2014 Jun 26;3:69. doi: 10.1186/2046-4053-3-69.

38.

Management of pregnancy associated venous-thromboembolism: a survey of practices.

Gándara E, Carrier M, Rodger MA.

Thromb J. 2014 Jun 2;12:12. doi: 10.1186/1477-9560-12-12. eCollection 2014.

39.

Is thrombophilia associated with placenta-mediated pregnancy complications? A prospective cohort study: reply.

Rodger MA, Langlois NJ.

J Thromb Haemost. 2014 Aug;12(8):1378-9. doi: 10.1111/jth.12632. Epub 2014 Jul 15. No abstract available.

40.

Treatment of venous thromboembolism.

Wells PS, Forgie MA, Rodger MA.

JAMA. 2014 Feb 19;311(7):717-28. doi: 10.1001/jama.2014.65. Review. Erratum in: JAMA. 2014 Jun 25;311(24):2545.

PMID:
24549552
41.

Is thrombophilia associated with placenta-mediated pregnancy complications? A prospective cohort study.

Rodger MA, Walker MC, Smith GN, Wells PS, Ramsay T, Langlois NJ, Carson N, Carrier M, Rennicks White R, Shachkina S, Wen SW.

J Thromb Haemost. 2014 Apr;12(4):469-78. doi: 10.1111/jth.12509.

42.

Major bleeding during secondary prevention of venous thromboembolism in patients who have completed anticoagulation: a systematic review and meta-analysis.

Castellucci LA, Le Gal G, Rodger MA, Carrier M.

J Thromb Haemost. 2014;12(3):344-8. doi: 10.1111/jth.12501. Review.

43.

Meta-analysis of low-molecular-weight heparin to prevent recurrent placenta-mediated pregnancy complications.

Rodger MA, Carrier M, Le Gal G, Martinelli I, Perna A, Rey E, de Vries JI, Gris JC; Low-Molecular-Weight Heparin for Placenta-Mediated Pregnancy Complications Study Group.

Blood. 2014 Feb 6;123(6):822-8. doi: 10.1182/blood-2013-01-478958. Epub 2013 Dec 19. Review.

44.

Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial.

Kahn SR, Shapiro S, Wells PS, Rodger MA, Kovacs MJ, Anderson DR, Tagalakis V, Houweling AH, Ducruet T, Holcroft C, Johri M, Solymoss S, Miron MJ, Yeo E, Smith R, Schulman S, Kassis J, Kearon C, Chagnon I, Wong T, Demers C, Hanmiah R, Kaatz S, Selby R, Rathbun S, Desmarais S, Opatrny L, Ortel TL, Ginsberg JS; SOX trial investigators.

Lancet. 2014 Mar 8;383(9920):880-8. doi: 10.1016/S0140-6736(13)61902-9. Epub 2013 Dec 6.

PMID:
24315521
45.

Intermediate doses of low-molecular-weight heparin for the long-term treatment of pregnancy thromboembolism. A systematic review.

Gándara E, Carrier M, Rodger MA.

Thromb Haemost. 2014 Mar 3;111(3):559-61. doi: 10.1160/TH13-06-0510. Epub 2013 Dec 5. Review. No abstract available.

PMID:
24306093
46.

Non-OO blood type influences the risk of recurrent venous thromboembolism. A cohort study.

Gándara E, Kovacs MJ, Kahn SR, Wells PS, Anderson DA, Chagnon I, Le Gal G, Solymoss S, Crowther M, Carrier M, Langlois N, Kovacs J, Little Ma J, Carson N, Ramsay T, Rodger MA.

Thromb Haemost. 2013 Dec;110(6):1172-9. doi: 10.1160/TH13-06-0488. Epub 2013 Sep 26.

PMID:
24067945
47.

Outpatient treatment of symptomatic pulmonary embolism: a systematic review and meta-analysis.

Piran S, Le Gal G, Wells PS, Gandara E, Righini M, Rodger MA, Carrier M.

Thromb Res. 2013 Nov;132(5):515-9. doi: 10.1016/j.thromres.2013.08.012. Epub 2013 Aug 28. Review.

PMID:
24035045
48.

Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis.

Castellucci LA, Cameron C, Le Gal G, Rodger MA, Coyle D, Wells PS, Clifford T, Gandara E, Wells G, Carrier M.

BMJ. 2013 Aug 30;347:f5133. doi: 10.1136/bmj.f5133. Review.

49.

Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial.

Anderson DR, Dunbar MJ, Bohm ER, Belzile E, Kahn SR, Zukor D, Fisher W, Gofton W, Gross P, Pelet S, Crowther M, MacDonald S, Kim P, Pleasance S, Davis N, Andreou P, Wells P, Kovacs M, Rodger MA, Ramsay T, Carrier M, Vendittoli PA.

Ann Intern Med. 2013 Jun 4;158(11):800-6. doi: 10.7326/0003-4819-158-11-201306040-00004.

PMID:
23732713
50.

An update on thrombophilia and placenta mediated pregnancy complications: what should we tell our patients?

Rodger MA.

Thromb Res. 2013 Jan;131 Suppl 1:S25-7. doi: 10.1016/S0049-3848(13)70015-X. Review.

PMID:
23452735

Supplemental Content

Loading ...
Support Center